High frequency of clinical conditions commonly associated with mitochondrial disorders in schizophrenia

被引:4
作者
Alonso, Yolanda [1 ,2 ]
Valiente-Palleja, Alba [1 ,2 ]
Verge, Begona [1 ,2 ]
Vilella, Elisabet [1 ,2 ]
Martorell, Lourdes [1 ,2 ]
机构
[1] Rovira & Virgili Univ URV, Univ Hosp Inst Pere Mata, Hlth Res Inst Pere Virgili IISPV, Reus, Spain
[2] Biomed Network Res Ctr Mental Hlth CIBERSAM, Madrid, Spain
关键词
schizophrenia; mitochondrial diseases; comorbidity; fatigue; seizures; DYSFUNCTION; COMORBIDITIES; MORTALITY; ILLNESS; FATIGUE;
D O I
10.1017/neu.2020.16
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: It has been hypothesised that neuropsychiatric symptoms, including psychosis, can be the result of a milder brain bioenergetic defect produced by mitochondrial dysfunction; however, mitochondrial dysfunction can be present in other organs or systems. The aim of the study was to investigate whether clinical conditions associated with mitochondrial disorders (CAMDs) were frequently present in schizophrenia. Methods: A previously used questionnaire regarding the CAMDs was administered to patients and controls in a direct interview with a trained psychiatrist. The frequencies of CAMDs in 164 patients with schizophrenia were compared to those in 156 age- and sex-matched controls. Results: Severe fatigue, seizures, constipation and diabetes were significantly more frequent in patients with schizophrenia than in control subjects and apparently not related to pharmacological treatment. Conclusion: The results of the present study suggest that multi-systemic mitochondrial dysfunction may be an underlying mechanism involved in schizophrenia.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 33 条
[1]  
American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI 10.1176/appi.books.9780890425596
[2]  
[Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158
[3]   From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism [J].
Castillo, Rolando I. ;
Rojo, Leonel E. ;
Henriquez-Henriquez, Marcela ;
Silva, Hernan ;
Maturana, Alejandro ;
Villar, Maria J. ;
Fuentes, Manuel ;
Gaspar, Pablo A. .
FRONTIERS IN NEUROSCIENCE, 2016, 10
[4]  
Chinnery P.F., GeneReviews
[5]   Mitochondrial disease and endocrine dysfunction [J].
Chow, Jasmine ;
Rahman, Joyeeta ;
Achermann, John C. ;
Dattani, Mehul T. ;
Rahman, Shamima .
NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (02) :92-104
[6]   Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study [J].
Crump, Casey ;
Winkleby, Marilyn A. ;
Sundquist, Kristina ;
Sundquist, Jan .
AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (03) :324-333
[7]   A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis [J].
Davis, Justin ;
Eyre, Harris ;
Jacka, Felice N. ;
Dodd, Seetal ;
Dean, Olivia ;
McEwen, Sarah ;
Debnath, Monojit ;
McGrath, John ;
Maes, Michael ;
Amminger, Paul ;
McGorry, Patrick D. ;
Pantelis, Christos ;
Berk, Michael .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 65 :185-194
[8]   Second-generation antipsychotics and constipation: A review of the literature [J].
De Hert, M. ;
Hudyana, H. ;
Dockx, L. ;
Bernagie, C. ;
Sweers, K. ;
Tack, J. ;
Leucht, S. ;
Peuskens, J. .
EUROPEAN PSYCHIATRY, 2011, 26 (01) :34-44
[9]   Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span [J].
Dieset, Ingrid ;
Andreassen, Ole A. ;
Haukvik, Unn K. .
SCHIZOPHRENIA BULLETIN, 2016, 42 (06) :1316-1319
[10]  
EU, 2016, FAZ, P1, DOI DOI 10.5194/ACP16-150752016